sorbisterit 15 g suukaudse/rektaalsuspensiooni pulber
fresenius medical care nephrologica deutschland gmbh - polüstüreensulfonaat - suukaudse/rektaalsuspensiooni pulber - 15g 30tk
sorbisterit suukaudse/rektaalsuspensiooni pulber
fresenius medical care nephrologica deutschland gmbh - polüstüreensulfonaat - suukaudse/rektaalsuspensiooni pulber - 949mg 1g 500g 1tk
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastilised ained - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
sorbisterit suukaudse/rektaalsuspensiooni pulber
ideal trade links uab - polüstüreensulfonaat - suukaudse/rektaalsuspensiooni pulber - 949mg 1g 500g 1tk